Date: Tuesday, June 14, 2016
Session Time: 4:30pm-6:00pm
Presentation Time: 5:30pm-5:42pm
Location: Room 310
A growing body of evidence shows that induction of long term transplant survival by “costimulation blockade” (CoB) regimens is impaired by inflammatory responses. In particular, multiple studies reported that engagement of toll like receptors (TLR) abrogates the tolerogenic effect of CoB. Despite the identification of type-1 interferons (TI-IFN) as mediators of this effect in multiple models, the target population and specific pathway used by TI-IFN to induce this effect are not known yet. To better understand how an inflammatory environment, and more specifically IFN-β, could interfere with the induction of transplant tolerance we studied their impact on the immunomodulatory properties of IL-10.
Mouse bulk T cells were isolated by negative-selection and Tmem and Treg subpopulations identified by flow cytometry. IL-10R expression and phospho-STAT3 induction (a key signaling step) after IL-10 and IL-6 stimulation in Tmem and Treg cells were measured via optimized flow cytometry techniques. The gene expression profile of T cell subsets exposed to TI-IFN was assessed by microarray and quantitative PCR analysis. Protein levels were measured by Western Blot.
Our studies show that following 48h of bystander incubation with IFN-β, Tmem and Treg subpopulations present a dramatic defect in the production of phospho-STAT3 in response to IL-10, but not to IL-6. Microarray and flow cytometry data indicated that this IL-10-specific unresponsiveness was not associated with reduction in surface IL-10R expression or an increase in SOCS (Suppressor of Cytokine Signaling) 1 and 3, nor with reduced STAT3 cytoplasmic availability.They however suggested a possible role of STAT1 in this process. Before and after IFN-β exposure, there is a complete reversal of the STAT1/STAT3 ratio in T cells. Moreover, we observed a stronger increase in phospho-STAT3 levels in STAT1-KO T cells after IL-10 stimulation.
Overall, these data reveal a promising new molecular mechanism where IFN-β interfere with IL-10 signaling in T cells by increasing levels of STAT1. Our data suggest that STAT1 exerts cross-competition with STAT3 for IL-10R binding, preventing its phosphorylation and activity. A targeted regulation of this mechanisms that counteract IL-10 suppressive functions could be a powerful tool to improve the efficacy of immunomodulatory strategies for transplant tolerance induction.
CITATION INFORMATION: Iglesias M, Arun A, Lee W, Brandacher G, Raimondi G. Type-I Interferon Induced Cross-Competition of IL-10 Signaling and Its Role in the Abrogation of Transplant Tolerance. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:Iglesias M, Arun A, Lee W, Brandacher G, Raimondi G. Type-I Interferon Induced Cross-Competition of IL-10 Signaling and Its Role in the Abrogation of Transplant Tolerance. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/type-i-interferon-induced-cross-competition-of-il-10-signaling-and-its-role-in-the-abrogation-of-transplant-tolerance/. Accessed January 24, 2020.
« Back to 2016 American Transplant Congress